Patent ID: 8642621

Claim:
A compound of the following formula, or a pharmaceutically acceptable salt thereof: wherein: —W is —Y; —Y is independently —Y 1 , —Y 2 , —Y 3 , —Y 4 , or —Y 5 ; —Y 1 is —OH; —Y 2 is independently —Y 2A , —Y 2B , or —Y 2C ; —Y 3 is independently —Y 3A , —Y 3B , or —Y 3c ; —Y 4 is independently —F, —Cl, —Br, or —I; —Y 5 is —CN; wherein: —Y 2A is —OR YA ; —Y 2B is —OR YB ; —Y 2C is —OR YC ; —Y 3A is —R YA ; —Y 3B is —R YB ; —Y 3C is —R YC ; wherein: each —R YA is saturated aliphatic C 1-6 alkyl; each —R YB is saturated aliphatic halo-C 1-6 alkyl; each —R YC is saturated aliphatic hydroxy-C 1-6 alkyl; and wherein: each of -J 1 , -J 2 , -J 3 , and -J 4 is —H; or each of -J 2 and -J 4 is —H; and -J 1 and -J 3 taken together form —CH 2 — or —CH 2 CH 2 —; or each of -J 1 and -J 3 is —H; and -J 2 and -J 4 taken together form —CH 2 — or —CH 2 CH 2 —; or each of -J 2 and -J 3 is —H; and -J 1 and -J 4 taken together form —CH 2 — or —CH 2 CH 2 —; and wherein: —R N is independently —H or —R NN ; —R NN is saturated aliphatic C 1-6 alkyl; and wherein: —R B1 is independently —H or —R BB ; —R B2 is independently —H or —R BB ; wherein: each —R BB is independently —RB BB1 , —R BB2 , or —R BB3 ; wherein: each —R BB1 is saturated aliphatic C 1-6 alkyl, and is optionally substituted with one or more substituents selected from —F, —OH, —OR BBB , —OCH 2 F, —OCHF 2 , —OCF 3 , —NH 2 , —NHR BBB , and —NR BBB 2 ; wherein each —R BBB is saturated aliphatic C 1-4 alkyl; each —R BB2 is independently —F, —Cl, —Br, or —I; each —R BB3 is —CN; and wherein: n is independently 0, 1, 2, 3, 4, or 5; each —R F is independently —R Z , —F, —Cl, —Br, —I, —CF 3 , —OH, —OR Z , —OCF 3 , —SR Z , —S(═O) 2 R Z , or —CN; and each —R Z is saturated aliphatic C 1-6 alkyl, and is optionally substituted with one or more substituents selected from —F, —Cl, —OH, —OR ZZ , —OCH 2 F, —OCHF 2 , and —OCF 3 ; wherein each —R ZZ is saturated aliphatic C 1-4 alkyl.